Labviva
Accelerating the science of LIFE
Accelerating the science of LIFE
Labviva, a United States based E-Commerce and Health Care startup, aims to revolutionize life sciences procurement with its AI-powered digital purchasing platform. The company, founded in 2017, provides complete transparency into the supply chain, integrating with existing purchasing software to offer actionable insights for better decision-making. Labviva's digital marketplace ensures unparalleled visibility into the procurement process, empowering informed decisions without interruptions to research. This innovative approach has attracted significant investment, with a $20.00M Series A investment secured on 27 March 2023 from prominent investors including B Capital Group, Biospring Partners, Glasswing Ventures, and Senator Investment Group. With a compelling vision encapsulated in the slogan "Accelerating the science of LIFE," Labviva is positioning itself as a disruptive force in the life sciences industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $20.00M | 4 |
|
27 Mar 2023 |
| Seed Round | $8.00M | 4 |
|
21 Jun 2021 |
| Venture Round | Unknown | 2 |
|
31 May 2020 |
| Seed Round | $2.00M | - | 22 Apr 2019 |
No recent news or press coverage available for Labviva.
We care about your data, and we'd love to use cookies make your experience better.
